Analysts See Bullishness for AMD; AMMO Beats Wall Street Estimates
- June 14th, 2023
- 330 views
Advanced Micro Devices, Inc. (Nasdaq: AMD), a leading technology company in the semiconductor industry, has garnered positive evaluations and price target increases from various reputable financial institutions.
The following institutions maintained a Buy rating for AMD, indicating their confidence in the company's performance:
Craig-Hallum: Raised the price target from $100 to $158.
Jefferies: Raised the price target from $100 to $145.
Mizuho: Raised the price target from $90 to $140.
Barclays: Raised the price target from $90 to $145.
Furthermore, other institutions also expressed positive sentiments toward AMD, emphasizing its favorable prospects:
BMO Capital: Maintained an Outperform rating and raised the price target from $110 to $150.
Susquehanna: Maintained a Positive rating and raised the price target from $120 to $145.
Wells Fargo: Maintained an Overweight rating and raised the price target from $120 to $150.
Raymond James: Maintained a Strong Buy rating and raised the price target from $110 to $145.
$AMD is currently trading at $127.79 in after-hours, reflecting a modest increase of $0.46 (+0.36%).
AMMO, Inc. (NASDAQ: POWW), a leading ammunition manufacturer and technology company, has announced its financial results for the fourth quarter of fiscal year 2023.
The company reported an adjusted earnings per share (EPS) of $0.03, surpassing the projections made by analysts who had anticipated a loss of $0.01 per share.
In after-hours, $POWW is trading at $2.34, up $0.30 (+14.70%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026




Member Login